OpenAI offers GPT-Rosalind-6 for biology research through trusted access, treating it as High in biology and Critical in cyber
OpenAI · System card
Read the source (opens in a new tab)- What happened
- OpenAI published a system card addendum on October 30, 2026 for GPT-Rosalind-6, a biology and drug discovery model that uses GPT-6 Astra's weights and is available only to approved customers.
- Key points
- Rosalind "has fewer refusals on dual-use biological queries" and supports some dual-use topics GPT-6 Astra may refuse, while still refusing requests for biological weaponization.
- Rated High in biological and chemical capability, below Critical: adjusted for refusals, it exceeds indicative High thresholds on three of four evaluations and meets none of four Critical thresholds.
- It takes GPT-6 Astra's Critical cybersecurity rating and below-High AI self-improvement rating, and adds "a more conservative cyber refusal boundary."
- Access rules match GPT-Rosalind-5.5's and do not widen eligibility beyond earlier announcements such as the Rosalind Academic Plan; outputs need human review before informing experiments, and OpenAI can revoke access for misuse.
- Evidence
- Company system card addendum. OpenAI says its biology evaluations test specific capabilities, not the full ability to cause biological harm, and that its Critical thresholds are preliminary estimates.
- Uncertain
- OpenAI does not publish the details of its biosecurity red-teaming of its misuse monitoring and enforcement, and says it is still repeating that test for GPT-Rosalind-6 now that it is deployed.